Bioactive Marine Drugs and Marine Biomaterials for Brain Diseases

Overview

Journal Mar Drugs

Publisher MDPI

Specialties Biology
Pharmacology

Date 2014 May 7

PMID 24798925

Citations 15

Authors

Clara Grosso

Patricia Valentao

Federico Ferreres

Paula B Andrade

Affiliations

Soon will be listed here.

Abstract

Marine invertebrates produce a plethora of bioactive compounds, which serve as inspiration for marine biotechnology, particularly in drug discovery programs and biomaterials development. This review aims to summarize the potential of drugs derived from marine invertebrates in the field of neuroscience. Therefore, some examples of neuroprotective drugs and neurotoxins will be discussed. Their role in neuroscience research and development of new therapies targeting the central nervous system will be addressed, with particular focus on neuroinflammation and neurodegeneration. In addition, the neuronal growth promoted by marine drugs, as well as the recent advances in neural tissue engineering, will be highlighted.

Citing Articles

Marine life as a source of anti-prostate cancer agents: an updated overview (2003-2023).

Hussain A, Sohail A, Akash M, Iqbal S, Rehman K, Imran M Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39976719 DOI: 10.1007/s00210-025-03886-6.

Fiscalin Derivatives as Potential Neuroprotective Agents.

Barreiro S, Silva B, Long S, Pinto M, Remiao F, Sousa E Pharmaceutics. 2022; 14(7).

PMID: 35890350 PMC: 9320635. DOI: 10.3390/pharmaceutics14071456.

High-throughput screening for amyloid- binding natural small-molecules based on the combinational use of biolayer interferometry and UHPLC-DAD-Q/TOF-MS/MS.

Guo M, Zhu F, Qiu W, Qiao G, Law B, Yu L Acta Pharm Sin B. 2022; 12(4):1723-1739.

PMID: 35847494 PMC: 9279722. DOI: 10.1016/j.apsb.2021.08.030.

Characteristics of Marine Biomaterials and Their Applications in Biomedicine.

Zhang H, Wu X, Quan L, Ao Q Mar Drugs. 2022; 20(6).

PMID: 35736175 PMC: 9228671. DOI: 10.3390/md20060372.

Biotechnological Innovations from Ocean: Transpiring Role of Marine Drugs in Management of Chronic Disorders.

Bhatia S, Makkar R, Behl T, Sehgal A, Singh S, Rachamalla M Molecules. 2022; 27(5).

PMID: 35268639 PMC: 8911953. DOI: 10.3390/molecules27051539.

References

Sakai R, Koike T, Sasaki M, Shimamoto K, Oiwa C, Yano A . Isolation, structure determination, and synthesis of neodysiherbaine A, a new excitatory amino acid from a marine sponge. Org Lett. 2001; 3(10):1479-82. DOI: 10.1021/ol015798l. View

Carter A . The importance of voltage-dependent sodium channels in cerebral ischaemia. Amino Acids. 1999; 14(1-3):159-69. DOI: 10.1007/BF01345257. View

Esbenshade T, Browman K, Bitner R, Strakhova M, Cowart M, Brioni J . The histamine H3 receptor: an attractive target for the treatment of cognitive disorders. Br J Pharmacol. 2008; 154(6):1166-81. PMC: 2483387. DOI: 10.1038/bjp.2008.147. View

Williams A, Ling G, McCabe R, Tortella F . Intrathecal CGX-1007 is neuroprotective in a rat model of focal cerebral ischemia. Neuroreport. 2002; 13(6):821-4. DOI: 10.1097/00001756-200205070-00017. View

Williams P, Sorribas A, Liang Z . New methods to explore marine resources for Alzheimer's therapeutics. Curr Alzheimer Res. 2010; 7(3):210-3. PMC: 3170562. DOI: 10.2174/156720510791050812. View

Mortari M, Cunha A, Ferreira L, dos Santos W . Neurotoxins from invertebrates as anticonvulsants: from basic research to therapeutic application. Pharmacol Ther. 2007; 114(2):171-83. DOI: 10.1016/j.pharmthera.2007.01.009. View

Ryoo S, Jeong H, Radnaabazar C, Yoo J, Cho H, Lee H . DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease. J Biol Chem. 2007; 282(48):34850-7. DOI: 10.1074/jbc.M707358200. View

Hu J, Schetz J, Kelly M, Peng J, Ang K, Flotow H . New antiinfective and human 5-HT2 receptor binding natural and semisynthetic compounds from the Jamaican sponge Smenospongia aurea. J Nat Prod. 2002; 65(4):476-80. DOI: 10.1021/np010471e. View

Ye Q, Zhang X, Huang B, Zhu Y, Chen X . Astaxanthin suppresses MPP(+)-induced oxidative damage in PC12 cells through a Sp1/NR1 signaling pathway. Mar Drugs. 2013; 11(4):1019-34. PMC: 3705385. DOI: 10.3390/md11041019. View

10.

Sakai R, Swanson G . Recent progress in neuroactive marine natural products. Nat Prod Rep. 2014; 31(2):273-309. PMC: 3955223. DOI: 10.1039/c3np70083f. View

11.

Valentino K, Newcomb R, Gadbois T, Singh T, Bowersox S, Bitner S . A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. Proc Natl Acad Sci U S A. 1993; 90(16):7894-7. PMC: 47249. DOI: 10.1073/pnas.90.16.7894. View

12.

Giugliano M . Calcium waves in astrocyte networks: theory and experiments. Front Neurosci. 2010; 3(2):160-1. PMC: 2751621. DOI: 10.3389/neuro.01.019.2009. View

13.

Ryoo S, Cho H, Lee H, Jeong H, Radnaabazar C, Kim Y . Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease. J Neurochem. 2007; 104(5):1333-44. DOI: 10.1111/j.1471-4159.2007.05075.x. View

14.

Dai J, Jimenez J, Kelly M, Williams P . Dictazoles: potential vinyl cyclobutane biosynthetic precursors to the dictazolines. J Org Chem. 2010; 75(7):2399-402. PMC: 2849972. DOI: 10.1021/jo902566n. View

15.

Hauser T, Hepler C, Kombo D, Grinevich V, Kiser M, Hooker D . Comparison of acetylcholine receptor interactions of the marine toxins, 13-desmethylspirolide C and gymnodimine. Neuropharmacology. 2012; 62(7):2239-50. DOI: 10.1016/j.neuropharm.2012.01.009. View

16.

Aiello A, DEsposito M, Fattorusso E, Menna M, Muller W, Perovic-Ottstadt S . Novel bioactive bromopyrrole alkaloids from the Mediterranean sponge Axinella verrucosa. Bioorg Med Chem. 2005; 14(1):17-24. DOI: 10.1016/j.bmc.2005.07.057. View

17.

Wan Y, Hur W, Cho C, Liu Y, Adrian F, Lozach O . Synthesis and target identification of hymenialdisine analogs. Chem Biol. 2004; 11(2):247-59. DOI: 10.1016/j.chembiol.2004.01.015. View

18.

Kew J, Kemp J . Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl). 2005; 179(1):4-29. DOI: 10.1007/s00213-005-2200-z. View

19.

Aoki S, Wei H, Matsui K, Rachmat R, Kobayashi M . Pyridoacridine alkaloids inducing neuronal differentiation in a neuroblastoma cell line, from marine sponge Biemna fortis. Bioorg Med Chem. 2003; 11(9):1969-73. DOI: 10.1016/s0968-0896(03)00086-5. View

20.

Kuhlmann T, Wendling U, Nolte C, Zipp F, Maruschak B, Stadelmann C . Differential regulation of myelin phagocytosis by macrophages/microglia, involvement of target myelin, Fc receptors and activation by intravenous immunoglobulins. J Neurosci Res. 2002; 67(2):185-90. DOI: 10.1002/jnr.10104. View